Cost of healthcare for patients with migraine in five European countries: Results from the International Burden of Migraine Study (IBMS)

L. M. Bloudek, M. Stokes, D. C. Buse, T. K. Wilcox, R. B. Lipton, P. J. Goadsby, S. F. Varon, A. M. Blumenfeld, Z. Katsarava, J. Pascual, M. Lanteri-Minet, P. Cortelli, P. Martelletti

Research output: Contribution to journalArticle

Abstract

Migraine is a disabling neurological disease that affects 14.7 % of Europeans. Studies evaluating the economic impact of migraine are complex to conduct adequately and with time become outdated as healthcare systems evolve. This study sought to quantify and compare direct medical costs of chronic migraine (CM) and episodic migraine (EM) in five European countries. Cross-sectional data collected via a web-based survey were screened for migraine and classified as CM (≥15 headache days/month) or EM (

Original languageEnglish
Pages (from-to)361-378
Number of pages18
JournalJournal of Headache and Pain
Volume13
Issue number5
DOIs
Publication statusPublished - Jul 2012

    Fingerprint

Keywords

  • Chronic migraine
  • Cost
  • Episodic migraine
  • France
  • Germany
  • Italy
  • Migraine
  • Resource utilization
  • Spain
  • United Kingdom

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology

Cite this

Bloudek, L. M., Stokes, M., Buse, D. C., Wilcox, T. K., Lipton, R. B., Goadsby, P. J., Varon, S. F., Blumenfeld, A. M., Katsarava, Z., Pascual, J., Lanteri-Minet, M., Cortelli, P., & Martelletti, P. (2012). Cost of healthcare for patients with migraine in five European countries: Results from the International Burden of Migraine Study (IBMS). Journal of Headache and Pain, 13(5), 361-378. https://doi.org/10.1007/s10194-012-0460-7